Analysis: Valiant Laboratories Limited

NSE:VALIANTLAB Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹548 cr

Research report

companyname: Valiant Laboratories Limited ticker: VALIANTLAB sector: Pharmaceuticals — Active Pharmaceutical Ingredients (API) manufacturing Valiant Laboratories Limited manufactures active pharmaceutical ingredients (APIs), the molecules that drug formulators turn into finished medicines. Its disclosed strength is a single molecule, Paracetamol. The company operates one disclosed manufacturing site, at Tarapur, had 84 permanent employees on March 31, 2026, and reported standalone FY26 revenue ...

Read the full report →
RS rating: 98 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Valiant Laboratories Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.